CN101199607B - Nose kang tea - Google Patents

Nose kang tea Download PDF

Info

Publication number
CN101199607B
CN101199607B CN200710009991XA CN200710009991A CN101199607B CN 101199607 B CN101199607 B CN 101199607B CN 200710009991X A CN200710009991X A CN 200710009991XA CN 200710009991 A CN200710009991 A CN 200710009991A CN 101199607 B CN101199607 B CN 101199607B
Authority
CN
China
Prior art keywords
rhizoma
tea
radix
nose
kang
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200710009991XA
Other languages
Chinese (zh)
Other versions
CN101199607A (en
Inventor
周鑫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200710009991XA priority Critical patent/CN101199607B/en
Publication of CN101199607A publication Critical patent/CN101199607A/en
Application granted granted Critical
Publication of CN101199607B publication Critical patent/CN101199607B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a therapeutic preparation containing reaction products originated from plant materials, in particular to a Bikang tea medicinal tea for curing rhinitis. The invention adopts the technical proposal that: the medicament is prepared by following ingredients by weight ratios: 1-3g of magnolia liliflora, 1-3g of ligusticum sinense, 2-5g of Astragalus root, 1-3g of broadleaf holly leaf, 1-3g of notopterygium incisium, 1-2g of cimicifuga foetida, 1-3g of hemlock parsley, 1-2g of dahurian angelica, 1-3g of parsnip, 1-3g of silkworm larva, 0.5-1.5g of asarum, 1-3g of herba schizonepetae and 1-3g of chrysanthemum. The medicinal tea is prepared by using the modern Chinese traditional medicine making process, a cup of tea can be taken before going to bed every night with safety and convenience, outstanding curative effect and easy persistence, and the invention can effectively solve the defects that the pathogenic QI in the body repels the property of a drug when taking the oral drug, and the drug can not be absorbed and is ejected from the stomach immediately, so the invention deserves promotion and application.

Description

Nose kang tea
Technical field
The present invention relates to contain the medicinal preparation that derives from the vegetable material product, especially belong to a kind of nose kang tea medicinal tea of treating rhinitis.
Background technology
Rhinitis refers to the inflammation of nasal membrane and submucous tissue, and its performance is varied.From pathological change, allergic rhinitis, sinusitis, chronic simple rhinitis, chronic hypertrophic rhinitis, atrophic rhinitis etc. are arranged; From the slow length that reaches the course of disease of the urgency of morbidity, can be divided into acute rhinitis and chronic rhinitis.In addition, some rhinitis are arranged, though morbidity is slowly, the course of disease continues longer, and specific pathogenesis is arranged, just thereby specific title is arranged, like allergic rhinitis (that is allergic rhinitis), medicamentous rhinitis etc.At present, though the method for treatment rhinitis inflammation is a lot, curative effect still can not be satisfactory.
Summary of the invention
The object of the present invention is to provide a kind of easy, economical, have no side effect and treat rhinitis nose kang tea medicinal tea evident in efficacy.
The technical scheme that the present invention taked is: it is that Chinese crude drug by following weight ratio is made into:
Flos Magnoliae 1-3g Rhizoma Ligustici 1-3g Radix Astragali 2-5g Folium Ilicis 1-3g Rhizoma Et Radix Notopterygii 1-3g
The windproof 1-3g Bombyx Batryticatus of Rhizoma Cimicifugae 1-2g Rhizoma Chuanxiong 1-3g Radix Angelicae Dahuricae 1-2g 1-3g
Herba Asari 0.5-1.5g Herba Schizonepetae 1-3g Flos Chrysanthemi 1-3g.
Beneficial effect of the present invention is: the present invention is based on the theory of " integration of edible and medicinal herbs, the doctor supports in like manner ", with dredge the meridian passage, lung qi dispersing is sensible, expelling wind and cold, and sensible expelling pathogenic factors from the exterior, nourshing Yin and drynsessmoistening prescription, heat-clearing and toxic substances removing is the Therapeutic Principle.Warp is clinical application in many ways, develops the nose kang tea medicinal tea of treatment rhinitis, the pure Chinese crude drug of its selected the Nature; Modern Chinese medicine processing technology with conventional is processed medicinal tea; Potion is made tea just before going to bed every night, safe ready, evident in efficacy, be easy to adhere to, and can effectively solve the oral medication pathogenic QI in the body and property of medicine phase cell is refused; Medicine is gone into stomach and is promptly told and can not receive the drawback of medicine, is worth of widely use.
Theory of Chinese medical science is inquired into: the traditional Chinese medical science thinks that rhinitis is that lung meridian is hot and suffocating owing to attacked by wind and cold, wind heat repeatedly, and clear respectful not normal, air flue is unclear, the failure of nose key, and the body fluid heap soil or fertilizer over and around the roots stagnates, and with the passing of time turns to turbid tears, grows stream and forms this disease like the deep pool.In addition, the heresy of wind and cold, wind heat is directly encroached on Naohu, causes that brain is not solid, is primary disease and ooze under the turbid tears.But be to become because of wind and cold condensates into Naohu with the damp and hot friendship steaming of the sun always, lung meridian is hot and suffocating all can not to cause rhinitis with brain gas is solid.And the clinical symptoms of rhinitis morbidity is different, very harmful, when influencing the physiological function of nasal cavity; Respiratory disorder can appear; Cause blood oxygen concentration and reduce, influence the function and the metabolism of other tissue and organ, and some occur like headache, dizzy, hypomnesis; Chest pain, uncomfortable in chest, listlessness etc., in addition can concurrent emphysema, severe complications such as pulmonary heart disease, asthma.The medicine that the present invention adopted is made up of pure Chinese crude drugs such as Flos Magnoliae, Rhizoma Ligustici, the Radix Astragali, Folium Ilicis, Rhizoma Et Radix Notopterygii, Rhizoma Cimicifugae, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, windproof, Bombyx Batryticatus, Herba Asari, Herba Schizonepetae, Flos Chrysanthemis.Brew with boiling water and drink as long as get a bag medicated tea before sleeping every night during use.Full side's combined effect dredging the meridian, QI and blood regulating, sensible, the sensible expelling pathogenic factors from the exterior of lung qi dispersing, strengthening healthy qi, adjustment internal organs negative and positive tend to balance the state of body imbalance, reach the purpose of disease preventing and treating.
The specific embodiment
Concrete formulation Example of the present invention is following:
Embodiment 1: it is that Chinese crude drug by following weight ratio is made into:
Flos Magnoliae 1g Rhizoma Ligustici 1g Radix Astragali 2g Folium Ilicis 1g Rhizoma Et Radix Notopterygii 1g
The windproof 1g Bombyx Batryticatus of Rhizoma Cimicifugae 1g Rhizoma Chuanxiong 1g Radix Angelicae Dahuricae 1g 1g
Herba Asari 0.5g Herba Schizonepetae 1g Flos Chrysanthemi 1g.
Embodiment 2: it is that Chinese crude drug by following weight ratio is made into:
Flos Magnoliae 3g Rhizoma Ligustici 3g Radix Astragali 5g Folium Ilicis 3g Rhizoma Et Radix Notopterygii 3g
The windproof 3g Bombyx Batryticatus of Rhizoma Cimicifugae 2g Rhizoma Chuanxiong 3g Radix Angelicae Dahuricae 2g 3g
Herba Asari 1.5g Herba Schizonepetae 3g Flos Chrysanthemi 3g.
Embodiment 3: it is that Chinese crude drug by following weight ratio is made into:
Flos Magnoliae 2g Rhizoma Ligustici 2g Radix Astragali 4g Folium Ilicis 2g Rhizoma Et Radix Notopterygii 2g
The windproof 2g Bombyx Batryticatus of Rhizoma Cimicifugae 2g Rhizoma Chuanxiong 2g Radix Angelicae Dahuricae 2g 2g
Herba Asari 1g Herba Schizonepetae 2g Flos Chrysanthemi 2g.
The present invention is made up of pure Chinese crude drugs such as Flos Magnoliae, Rhizoma Ligustici, the Radix Astragali, Folium Ilicis, Rhizoma Et Radix Notopterygii, Rhizoma Cimicifugae, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, windproof, Bombyx Batryticatus, Herba Asari, Herba Schizonepetae, Flos Chrysanthemis; Adopt conventional modern Chinese medicine processing technology; Through cut into slices, pulverize, mix homogeneously, the tea bag inner packing of packing into becomes medicated tea.
Brew with boiling water and drink as long as get a bag medicated tea before sleeping every night when the present invention uses.
Therapeutic outcome of the present invention:
According in " the disease of tcm diagnosis criterion of therapeutical effect " of State Administration of Traditional Chinese Medicine promulgation about the efficacy assessment standard of rhinitis:
Recovery from illness: sniffle disappears, and the nasal cavity inspection is normal, nasal cavity cleaning, and BITONG gas is good, and the X line is taken the photograph sheet and is shown that the hole chamber is clear, does not have recurrence more than 3 months;
Produce effects: sniffle disappears basically, and BITONG gas is good, and the glutinous on a small quantity tears of nasal cavity, X line are taken the photograph apparent slightly the increasing of sheet demonstration hole chamber density;
Effectively: sniffle alleviates, and the pus tears obviously reduce, sxs such as mucosa hyperemia, concha nasalis enlargement;
Invalid: symptom and sign do not have to change to wait and judge efficacy result.
And with reference to " eye, hals,Nasen und Ohrenheilkunde medical diagnosis on disease standard ", all case is all made diagnosis according to medical history, the inspection of nostril, front and back, nasal sinuses X-ray film or CT scan.
Below all medical records all from prosperous subhealth state institute of week, case is collected and to be lasted one-year age.76 routine rhinitis patients, male 45 examples, women 31 examples; The oldest person 46 years old, age reckling 13 years old.Chronic simple rhinitis 32 examples wherein, allergic rhinitis 11 examples, chronic hypertrophic rhinitis 10 examples, sinusitis 14 examples, atrophic rhinitis's 7 examples.
Use " nose kang tea " after three months, cure 59 examples among the 76 routine patients, account for 77.6%; Produce effects 8 examples account for 10.5%; Effective 4 examples account for 5.3%; Invalid 5 examples account for 6.6%.Treated back 3 months~1 year, and followed up a case by regular visits to 47 patients, still do not have 1 example recurrence.

Claims (4)

1. nose kang tea is characterized in that: it is that Chinese crude drug by following weight ratio is made into:
Flos Magnoliae 1-3g Rhizoma Ligustici 1-3g Radix Astragali 2-5g Folium Ilicis 1-3g Rhizoma Et Radix Notopterygii 1-3g
The windproof 1-3g Bombyx Batryticatus of Rhizoma Cimicifugae 1-2g Rhizoma Chuanxiong 1-3g Radix Angelicae Dahuricae 1-2g 1-3g
Herba Asari 0.5-1.5g Herba Schizonepetae 1-3g Flos Chrysanthemi 1-3g.
2. according to the said nose kang tea of claim 1, it is characterized in that: it is that Chinese crude drug by following weight ratio is made into:
Flos Magnoliae 1g Rhizoma Ligustici 1g Radix Astragali 2g Folium Ilicis 1g Rhizoma Et Radix Notopterygii 1g
The windproof 1g Bombyx Batryticatus of Rhizoma Cimicifugae 1g Rhizoma Chuanxiong 1g Radix Angelicae Dahuricae 1g 1g
Herba Asari 0.5g Herba Schizonepetae 1g Flos Chrysanthemi 1g.
3. according to the said nose kang tea of claim 1, it is characterized in that: it is that Chinese crude drug by following weight ratio is made into:
Flos Magnoliae 3g Rhizoma Ligustici 3g Radix Astragali 5g Folium Ilicis 3g Rhizoma Et Radix Notopterygii 3g
The windproof 3g Bombyx Batryticatus of Rhizoma Cimicifugae 2g Rhizoma Chuanxiong 3g Radix Angelicae Dahuricae 2g 3g
Herba Asari 1.5g Herba Schizonepetae 3g Flos Chrysanthemi 3g.
4. according to the said nose kang tea of claim 1, it is characterized in that: it is that Chinese crude drug by following weight ratio is made into:
Flos Magnoliae 2g Rhizoma Ligustici 2g Radix Astragali 4g Folium Ilicis 2g Rhizoma Et Radix Notopterygii 2g
The windproof 2g Bombyx Batryticatus of Rhizoma Cimicifugae 2g Rhizoma Chuanxiong 2g Radix Angelicae Dahuricae 2g 2g
Herba Asari 1g Herba Schizonepetae 2g Flos Chrysanthemi 2g.
CN200710009991XA 2007-12-11 2007-12-11 Nose kang tea Expired - Fee Related CN101199607B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200710009991XA CN101199607B (en) 2007-12-11 2007-12-11 Nose kang tea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200710009991XA CN101199607B (en) 2007-12-11 2007-12-11 Nose kang tea

Publications (2)

Publication Number Publication Date
CN101199607A CN101199607A (en) 2008-06-18
CN101199607B true CN101199607B (en) 2012-04-18

Family

ID=39515088

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200710009991XA Expired - Fee Related CN101199607B (en) 2007-12-11 2007-12-11 Nose kang tea

Country Status (1)

Country Link
CN (1) CN101199607B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104815167A (en) * 2015-05-15 2015-08-05 王健军 Traditional Chinese medicine preparation for treating rhinitis
CN105168749A (en) * 2015-09-24 2015-12-23 烟台瑞智生物医药科技有限公司 Traditional Chinese medicine composite for treating wind-cold affecting lung syndrome type secretory otitis media
CN107714840A (en) * 2017-11-27 2018-02-23 竹溪县明俊意蜂养殖专业合作社 A kind of Chinese medicine for treating rhinitis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1265909A (en) * 1999-03-03 2000-09-13 朱维新 Capsule for treating rhinitis
CN1316251A (en) * 2000-04-04 2001-10-10 张忠贵 Capsule for treating nasosinusitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1265909A (en) * 1999-03-03 2000-09-13 朱维新 Capsule for treating rhinitis
CN1316251A (en) * 2000-04-04 2001-10-10 张忠贵 Capsule for treating nasosinusitis

Also Published As

Publication number Publication date
CN101199607A (en) 2008-06-18

Similar Documents

Publication Publication Date Title
CN103463609A (en) Traditional Chinese medicine oral decoction for treating upper respiratory infection and preparation method for Chinese patent medicine of traditional Chinese medicine oral decoction
CN102100856A (en) Nano traditional Chinese medicine for treating bronchial asthma and preparation technology
CN102813839B (en) Compound medicine for treating cluster headache syndrome
CN102526314A (en) Medicament for treating inguinal hernia and preparation method for medicament
CN101843694A (en) Chinese medicament for treating chronic hepatitis
CN101199607B (en) Nose kang tea
CN104353029A (en) Lung-moistening tangerine peel paste and preparation method thereof
CN102908396B (en) Chinese medicinal composition for promoting sleeping and preparation method thereof
CN102973785B (en) Traditional Chinese medicine for treatment of diabetic cardiomyopathy
CN104940642A (en) Dendrobium officinale health care wine having kidney tonifying function and method for preparing the same
CN108671165A (en) A kind of traditional Chinese herbal decoction for treating female climacteric syndrome
CN107582702A (en) Medicine Wax composition for traditional Chinese medical science wax therapy and preparation method thereof
CN106138785A (en) One treats neurasthenic Chinese medicine composition and preparation method thereof
CN104353045A (en) Walnut cream with asthma preventing effect
CN110384785A (en) A kind of external application Chinese medicine medical fluid and preparation method thereof for treating virus flu
CN100348252C (en) Chinese medicinal product for protecting liver and freezing bowel
CN104367975A (en) Flos farfarae paste for relieving cough and eliminating phlegm
CN103599185B (en) A kind of Chinese medicine composition being used for the treatment of headache
CN102319348B (en) Medicament for treating chronic pharyngitis
CN101843707B (en) Chinese medicament for treating chronic hepatitis
CN105832885A (en) Traditional Chinese medicine composition for treating insomnia
CN101112602B (en) Medicine for treating pharyngitis and method for preparing the same
CN105412561A (en) Medicine for treating anhypnia
CN105169324A (en) Chinese herba preparation for prevention and treatment of common cold due to wind-cold
CN101703590B (en) Chinese medicament for treating coronary disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120418

Termination date: 20121211